Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip Bischoff

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Oncogene|October 30, 2024
GPA33 expression in colorectal cancer can be induced by WNT inhibition and targeted by cellular therapyTeresa Börding, Tobias Janik, Philip Bischoff, et al.
Medicine|January 12, 2021
PD-L1 - inhibitors in neuroendocrine neoplasia: Results from a real-life studyBurcin Özdirik, Henning Jann, Philip Bischoff, et al.
Cellular Oncology (Dordrecht, Netherlands)|February 1, 2024
Robust detection of clinically relevant features in single-cell RNA profiles of patient-matched fresh and formalin-fixed paraffin-embedded (FFPE) lung cancer tissueAlexandra Trinks, Miha Milek, Dieter Beule, et al.
Transplantation Proceedings|August 6, 2022
Liver Transplantation for Metamizole induced Acute Liver FailureJulian Pohl, Philip Bischoff, Robert Oellinger, et al.
Nucleic Acids Research|January 11, 2023
Single-cell gene regulatory network prediction by explainable AIPhilipp Keyl, Philip Bischoff, Gabriel Dernbach, et al.
Iscience|November 9, 2020
Estrogens Determine Adherens Junction Organization and E-Cadherin Clustering in Breast Cancer Cells via AmphiregulinPhilip Bischoff, Marja Kornhuber, Sebastian Dunst, et al.
European Journal of Immunology|October 7, 2025
Imaging Mass Cytometry-Based Immune Profiling of Human Peyer's Patches in Patients with Crohn's DiseaseAdrian Huck, Yasmina Rodriguez-Sillke, Christian Bojarski, et al.
BMC Cancer|October 29, 2020
The majority of β-catenin mutations in colorectal cancer is homozygousAlexander Arnold, Moritz Tronser, Christine Sers, et al.
BMC Cancer|November 27, 2020
Correction to: The majority of β-catenin mutations in colorectal cancer is homozygousAlexander Arnold, Moritz Tronser, Christine Sers, et al.
BMC Endocrine Disorders|February 21, 2024
First effectiveness data of lenvatinib and pembrolizumab as first-line therapy in advanced anaplastic thyroid cancer: a retrospective cohort studyDominik Soll, Philip Bischoff, Anne Frisch, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Oncogene|October 30, 2024
GPA33 expression in colorectal cancer can be induced by WNT inhibition and targeted by cellular therapyTeresa Börding, Tobias Janik, Philip Bischoff, et al.
Medicine|January 12, 2021
PD-L1 - inhibitors in neuroendocrine neoplasia: Results from a real-life studyBurcin Özdirik, Henning Jann, Philip Bischoff, et al.
Cellular Oncology (Dordrecht, Netherlands)|February 1, 2024
Robust detection of clinically relevant features in single-cell RNA profiles of patient-matched fresh and formalin-fixed paraffin-embedded (FFPE) lung cancer tissueAlexandra Trinks, Miha Milek, Dieter Beule, et al.
Transplantation Proceedings|August 6, 2022
Liver Transplantation for Metamizole induced Acute Liver FailureJulian Pohl, Philip Bischoff, Robert Oellinger, et al.
Nucleic Acids Research|January 11, 2023
Single-cell gene regulatory network prediction by explainable AIPhilipp Keyl, Philip Bischoff, Gabriel Dernbach, et al.
Iscience|November 9, 2020
Estrogens Determine Adherens Junction Organization and E-Cadherin Clustering in Breast Cancer Cells via AmphiregulinPhilip Bischoff, Marja Kornhuber, Sebastian Dunst, et al.
European Journal of Immunology|October 7, 2025
Imaging Mass Cytometry-Based Immune Profiling of Human Peyer's Patches in Patients with Crohn's DiseaseAdrian Huck, Yasmina Rodriguez-Sillke, Christian Bojarski, et al.
BMC Cancer|October 29, 2020
The majority of β-catenin mutations in colorectal cancer is homozygousAlexander Arnold, Moritz Tronser, Christine Sers, et al.
BMC Cancer|November 27, 2020
Correction to: The majority of β-catenin mutations in colorectal cancer is homozygousAlexander Arnold, Moritz Tronser, Christine Sers, et al.
BMC Endocrine Disorders|February 21, 2024
First effectiveness data of lenvatinib and pembrolizumab as first-line therapy in advanced anaplastic thyroid cancer: a retrospective cohort studyDominik Soll, Philip Bischoff, Anne Frisch, et al.
Pageof 3